Wenquan B. Wang

270 Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

Journal: Cancer research

Published: January 22, 2026

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.

Journal: Journal of translational medicine

Published: January 14, 2026

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Journal: Molecular biomedicine

Published: October 24, 2025

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 19, 2025

CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human.

CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 09, 2025

Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices.

Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices.

Journal: Cancer metastasis reviews

Published: May 30, 2025

The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in Pancreatic Cancer.

The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 13, 2025

The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape.

The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 29, 2024

Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges.

Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges.

Journal: Journal of translational medicine

Published: December 24, 2024

Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study.

Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study.

Journal: International journal of surgery (London, England)

Published: November 27, 2024

Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).

Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).

Journal: Journal of hepato-biliary-pancreatic sciences

Published: August 16, 2024

First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review.

First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review.

Journal: Discover oncology

Published: July 02, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026